Fig. 25.
PDT-mediated ferroptosis cancer nanomedicine with MRI/FI guidance. (a) Preparation and characterization of Fe3O4@PGL NPs. (b) Real-time FI using Fe3O4@PGL NPs and their biodistribution. (c) MR contrast enhancing property of Fe3O4@PGL NPs. (d) In vivo PDT of Fe3O4@PGL NPs. Reproduced with permission [127]. Copyright 2021, American Chemical Society.